Details for Patent: 5,317,032
✉ Email this page to a colleague
Summary for Patent: 5,317,032
Title: | Prostaglandin cathartic |
Abstract: | The present invention relates to cathartics comprising 15-keto-16-halogen-PGs as an essential ingredient without substantive side-effects; the catharic effect is thought mainly caused by an enteropooling effect. |
Inventor(s): | Ueno; Ryuzo (Nishinomiya, JP), Ueno; Ryuji (Nishinomiya, JP), Kuno; Sachiko (Takarazuka, JP), Oda; Tomio (Itami, JP) |
Assignee: | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (Osaka, JP) |
Application Number: | 07/996,495 |
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 5,317,032
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,317,032
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 62-250163 | Oct 02, 1987 |
International Family Members for US Patent 5,317,032
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 78465 | ⤷ Try a Trial | |||
Australia | 2292088 | ⤷ Try a Trial | |||
Australia | 609883 | ⤷ Try a Trial | |||
Canada | 1312014 | ⤷ Try a Trial | |||
Germany | 3873007 | ⤷ Try a Trial | |||
European Patent Office | 0310305 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |